Yes, it's got me beat. The fundamentals for NML are sound. Hard to understand the monkey business that seems to be happening. Anyway, I'm in it for the long haul.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025